Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes
NCT ID: NCT03134417
Last Updated: 2021-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
109 participants
INTERVENTIONAL
2016-02-01
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
How Does Magnesium Status Influence Calcium Homeostasis?
NCT01593501
Hypovitaminosis D and an Inadequate PTH Response in Chronic Liver Disease Patients
NCT00599352
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
NCT01018849
Vitamin D3 Supplementation for Heart Failure Patients
NCT01636570
Vitamin D Supplementation for the Prevention of Cardiovascular Risk
NCT02020694
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D and magnesium
Daily oral vitamin D (1000 IU) and magnesium (360 mg) supplement
Vitamin D and magnesium
Daily vitamin D and magnesium supplements are given to participants daily for 12 weeks.
Vitamin D
Daily oral vitamin D (1000 IU) supplement
Vitamin D
Daily vitamin D supplements are given to participants daily for 12 weeks.
Placebo
Daily oral placebo (cellulose)
Placebo
Daily placebo are given to participants daily for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D and magnesium
Daily vitamin D and magnesium supplements are given to participants daily for 12 weeks.
Vitamin D
Daily vitamin D supplements are given to participants daily for 12 weeks.
Placebo
Daily placebo are given to participants daily for 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 30-70 years of age
Exclusion Criteria
* Pre-existing chronic medical conditions or medications know to influence energy, vitamin D, magnesium and calcium metabolism, levels of blood glucose, lipids and blood pressure
* Individuals taking vitamin D and magnesium supplement greater than the Recommended Daily allowance
* Participants taking any medications or have disease known to influence calcium or bone metabolism
30 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Heart Association
OTHER
Drexel University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Drexel University Nutrition Sciences Research Lab
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dall RD, Cheung MM, Shewokis PA, Altasan A, Volpe SL, Amori R, Singh H, Sukumar D. Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial. Nutr Res. 2023 Feb;110:33-43. doi: 10.1016/j.nutres.2022.12.005. Epub 2022 Dec 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1407002973
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.